A Bispecific Enediyne-Energized Fusion Protein Containing Ligand-Based and Antibody-Based Oligopeptides against Epidermal Growth Factor Receptor and Human Epidermal Growth Factor Receptor 2 Shows Potent Antitumor ActivityCLINICAL CANCER RESEARCHIF10.22010-03-3145OAAI
未登录.png){kind=icon}
未登录
